Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2001, p. 1700-1704, Vol. 45, No. 6
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1700-1704.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Proinflammatory Activity of a Cecropin-Like
Antibacterial Peptide from Helicobacter pylori
Johan
Bylund,1,*
Thierry
Christophe,2
Francois
Boulay,2
Thomas
Nyström,3
Anna
Karlsson,1 and
Claes
Dahlgren1
The Phagocyte Research Laboratory, Department
of Medical Microbiology and Immunology,1 and
Department of Cell and Molecular
Biology-Microbiology,3 University of
Göteborg, Göteborg, Sweden, and DBMS/BBSI (UMR
5092 CEA/CNRS/UJF) CEA-Grenoble, France2
Received 23 October 2000/Returned for modification 23 January
2001/Accepted 1 March 2001
 |
ABSTRACT |
Helicobacter pylori, the bacterial pathogen associated
with gastritis and peptic ulcers, is highly successful in establishing infection in the human gastric mucosa, a process typically associated with massive infiltration of inflammatory cells. Colonization of the
mucosa is suggested to be facilitated by H. pylori-produced cecropin-like peptides with antibacterial properties, giving the microbe a competitive advantage over other bacteria. We show that a
cecropin-like antibacterial peptide from H. pylori,
Hp(2-20), not only has a potent bactericidal effect but also induces
proinflammatory activities in human neutrophils, e.g., upregulation of
integrins (Mac-1), induction of chemotaxis, and activation of the
oxygen radical producing NADPH-oxidase. Furthermore, we show that these effects are mediated through binding of Hp(2-20) to the promiscuous, G-protein-linked lipoxin A4 receptor-formyl peptide-like
receptor 1.
 |
INTRODUCTION |
The stomach mucosa infected with
Helicobacter pylori, the causative agent of gastritis and
peptic ulcers, typically shows massive infiltration of inflammatory
cells. It is generally believed that the inflammatory response causes
the destruction of the host mucosal tissue, a process that is probably
beneficial for H. pylori by promoting a release of nutrients
from the epithelial lining and enabling bacterial growth and
persistence in the mucosal tissue (2). Proinflammatory
proteins and peptides, generated during bacterial growth, may thus play
an important role in the pathogenesis of H. pylori-associated disease (20, 22). Since the induced mucosal damage closely correlates with the infiltration of neutrophils (15), proteins and peptides that can activate these
inflammatory cells are of particular interest (1, 23).
H. pylori survival in the mucosal lining is dependent on a
number of different bacterial virulence features, including production of a vacuolating cytotoxin and an ability to resist phagocytic killing
(1, 9). In addition, H. pylori persistence in
the mucosa has been suggested to be facilitated also by antibacterial products released from the bacterium. As H. pylori itself is
resistant to its antibacterial products, a release of these compounds
would give H. pylori a competitive advantage over other
microorganisms (21a).
The antibacterial activity of H. pylori has been traced to
cecropin-like peptides derived from the amino-terminal part of its
ribosomal protein L1 (RpL1) (21a). Cecropins are a group of antibacterial peptides first discovered in the context of insect immunity, later found in higher organisms (e.g., mammals), and recently, also identified in a bacterium (for a review, see reference 3). It has therefore been suggested that cecropins have
their evolutionary origin in a bacterial rpl1 gene
(21a). The cecropins are composed of two amphipathic
-helices joined by a hinge (3), and one of the most
potent of the antibacterial cecropin-like H. pylori
peptides, Hp(2-20), is composed of one such cecropin-like helix. The
mechanism by which the cecropins exercise their bactericidal effect is
not yet fully understood but is thought to involve formation of pore
structures, leading to depolarization of the bacterial membrane
(12). Whereas the molecular mechanisms behind the
resistance of H. pylori to its own antibacterial peptides
are unknown, the presence of cholesterol seems to protect eukaryotic
membranes against the lytic activity (3).
The aim of the present study was to investigate the effect of the
antibacterial peptide Hp(2-20) with respect to its proinflammatory activity on human neutrophil granulocytes, as these cells are key
components in the inflammatory response evoked by H. pylori. We found that the peptide is chemotactic for neutrophils, that it
induces mobilization of adhesion molecules to the cell surface, and
that it activates the NADPH-oxidase. The receptor activated by Hp(2-20)
was found to be the lipoxin A4 receptor-formyl
peptide-like receptor 1 (LXA4R/FPRL1).
 |
MATERIALS AND METHODS |
Peptides.
A cecropin-like peptide, Hp(2-20), with a sequence
(AKKVFKRLEKLFSKIQNDK) identical to that of the
amino-terminal part of ribosomal protein L1 in H. pylori,
was synthesized and purified by high-pressure liquid chromatography
(HPLC) by Innovagen (Lund, Sweden). The peptide was dissolved in water
and stored at
70°C until use. The hexapeptide
Trp-Lys-Tyr-Met-Val-D-Met-NH2 (WKYMVm)
was synthesized and purified by HPLC by Alta Bioscience (University of
Birmingham, Birmingham, United Kingdom), and the formylated peptides
formyl-Met-Leu-Phe (fMLF) and formyl-Met-Leu-Phe-Lys (fMLFK) were from
Sigma Chemical Co. (St. Louis, Mo.). These peptides were dissolved in
dimethyl sulfoxide to 10 mM and stored at
70°C until use. Further
dilutions of all peptides were made in Krebs-Ringer phosphate buffer
containing glucose (10 mM), Ca2+ (1 mM), and
Mg2+ (1.5 mM) (KRG; pH 7.3). The lipopolysaccharide content
in the buffers used was less than 0.15 ng/ml.
Isolation of human neutrophils.
Blood neutrophils were
isolated from buffy coats from healthy blood donors by dextran
sedimentation and Ficoll-Paque gradient centrifugation
(5). The cells were washed and resuspended
(107/ml) in KRG and stored on melting ice until use.
Antimicrobial assay.
Escherichia coli bacteria of
strain MG1655 were grown overnight in Luria broth at 37°C on a rotary
shaker. The bacteria were washed and diluted in phosphate-buffered
saline to a density of approximately 105 bacteria/ml. The
Hp(2-20) peptide was added to the bacteria at various concentrations,
and these samples were then incubated at 37°C for 15 min, after which
10-µl aliquots were diluted and plated onto nutrient agar plates for
determination of viable counts.
Mobilization of Mac-1.
Mobilization of subcellular
organelles was followed by measurement of the level of exposure of
Mac-1 (CD11b/CD18) on the neutrophil surface. Neutrophils were
preincubated at 37°C for 5 min, supplemented with the peptides or KRG
(control), and incubated for another 10 min at 37°C. After fixation
and washing of the cells, the cells were labeled with
phycoerythrin-conjugated monoclonal antibodies specific for CD11b
(clone 12 catalog no. 347550 [Becton Dickinson, Mountain View,
Calif.]; 10 µl to a cell pellet of 106 cell) and
examined by FACScan (Becton Dickinson) analysis (10).
Neutrophil chemotaxis.
Neutrophil chemotaxis was determined
with ChemoTx multiwell chambers (Neuroprobe Inc., Gaithersburg, Md.)
according to the instructions given by the manufacturer. In short,
neutrophils were suspended in KRG supplemented with bovine serum
albumin (BSA; 0.3% [wt/vol]), and samples (30 µl of
106 cells/ml) were placed on top of 3-µm-pore-size
polycarbonate filters. Various concentrations of the different
peptides, diluted in KRG-BSA, were applied to the lower reservoir
(below the filter). The neutrophils were allowed to migrate through the
filters, and the accumulation of cells in the lower compartments was
determined after a 90-min incubation period at 37°C. For
quantification, the content of myeloperoxidase was assessed in the
lysates of transmigrated cells by adding a peroxidase substrate
(o-phenylenediamine; Dako A/S, Glostrup, Denmark). The
maximal number of cells recovered in the lower compartment (achieved
with the highest concentration of attractant) was about 15% of the
number added to the top of the filter.
Neutrophil NADPH-oxidase activity.
The NADPH-oxidase
activity was determined with luminol- and isoluminol-enhanced
chemiluminescence (CL) systems that allow us to measure the released
reactive oxygen species (ROS) as well as the ROS generated inside the
cells (11). The CL activity was measured in a six-channel
Biolumat LB 9505 (Berthold Co., Wildbad, Germany) instrument by using
disposable 4-ml polypropylene tubes with a 180- or 360-µl reaction
mixture containing 2 × 105 neutrophils. The tubes
used for measurement of extracellular ROS release contained horseradish
peroxidase (a cell-impermeant peroxidase; 4 U) and isoluminol (a
cell-impermeant CL substrate; 2 × 10
5 M). Tubes
used for measurement of intracellular ROS generation contained
superoxide dismutase (a cell-impermeant scavenger for O2
), catalase (a cell-impermeant scavenger
for H2O2), and luminol (a cell-permeant CL
substrate). When the NADPH-oxidase inhibitor diphenyleneiodonium (from
Sigma) was used, the inhibitor was added to the cells
(10
5 M) prior to equilibration. The tubes were
equilibrated in the Biolumat instrument for 5 min at 37°C, after
which the stimulus (20 or 40 µl) was added. The light emission was
recorded continuously.
Changes in cytosolic calcium in HL-60 cells expressing FPRL1 and
FPR.
Stable expression of the formyl peptide receptor (FPR) and
FPRL1 in undifferentiated HL-60 cells was obtained as described earlier
(10), and their interaction with Hp(2-20) was determined by the ability of the peptide to mobilize intracellular calcium. Cells
were loaded with 2 µM Fura 2-AM (Molecular Probes, Eugene, Oreg.) for
30 min at 37°C, washed, and resuspended in RPMI without phenol red.
The measurements were carried out with a SPEX FluoroMAX fluorescence
spectrophotometer with an excitation wavelength of 340 nm and an
emission wavelength of 505 nm. Intracellular free calcium
concentrations were calculated by the formula
Kd(F
Fmin)/(Fmax
F) with a Kd for Fura-2 of 224 nM
(7). Fmax is the fluorescence in
the presence of 0.04% Triton X-100, and Fmin is
the fluorescence obtained after addition of 5 mM EGTA plus 30 mM
Tris-HCl (pH 7.4).
 |
RESULTS AND DISCUSSION |
Proinflammatory and antibacterial activities of Hp(2-20).
Neutrophil adhesion and endothelial transmigration are, in part,
regulated at the level of integrin mobilization to the cell surface;
i.e., these adhesion molecules, which are required for firm adhesion to
the vessel wall, can be mobilized from intracellular organelles upon
cell activation (4). To investigate if Hp(2-20) could
induce granule mobilization, we measured the exposure of the integrin
Mac-1 on the neutrophil surface after incubation with the peptide. We
found that Hp(2-20) induced Mac-1 mobilization (Fig.
1A) in a dose-dependent manner at
concentrations similar to those required for a prominent antibacterial
effect (Fig. 1B). The maximal level of Mac-1 mobilization was
comparable to that induced by the well-characterized neutrophil
chemoattractant fMLF (27). The Mac-1 integrins are stored
in neutrophil secretory organelles that supplement the plasma membrane
not only with novel adhesion molecules required for adhesion to
endothelial linings but also with chemoreceptors required for
neutrophil extravasation into an infected tissue (26). The
effect of Hp(2-20) on neutrophil migration was subsequently
investigated. We found that Hp(2-20), in addition to inducing increased
integrin expression, also promoted neutrophil chemotaxis (Fig.
2). The maximal migration obtained in
response to Hp(2-20) was comparable to the maximal migration achieved
with fMLF (Fig. 2, inset).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Neutrophil activation and bactericidal effect of
Hp(2-20). (A) Hp(2-20) induces Mac-1 mobilization in human neutrophils.
Surface exposure of the integrin Mac-1 on neutrophils after stimulation
with Hp(2-20) (100 µM; dotted line) and fMLF (50 nM; solid line) are
shown as histograms from a representative FACScan analysis. (B)
Hp(2-20) induced Mac-1 mobilization in a dose-dependent manner at
concentrations similar to those required for a prominent antibacterial
effect. The relative increases in Mac-1 surface exposure (open circles)
were calculated from the mean fluorescence intensities of cells
activated with different concentrations of Hp(2-20) and are expressed
as percentages of the value obtained with unstimulated cells. The
results are given as means ± standard deviations (n = 4). The surviving fraction of E. coli after 15 min of
incubation with the indicated Hp(2-20) concentrations (closed boxes) is
also shown (representative experiment), demonstrating the bactericidal
effect of the peptide.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Hp(2-20)-induced chemotaxis. Hp(2-20) induces
chemotactic activity in human neutrophils to a degree comparable to
that of fMLF. Neutrophil transmigration after 90 min of incubation at
37°C in response to different Hp(2-20) concentrations is shown. The
inset depicts the maximal level of transmigration obtained with
Hp(2-20) (100 µM) and fMLF (10 nM). Data are expressed as the
percentage of transmigrated cells and are given as the means + standard deviations (n = 3). The spontaneous migration
was constantly about 1%.
|
|
Hp(2-20)-induced release of ROS.
Many neutrophil
chemoattractants are also activators of the neutrophil NADPH-oxidase,
which transports electrons from cytoplasmic NADPH across the membrane
to molecular oxygen, producing toxic oxygen radicals (i.e., superoxide
anion and hydrogen peroxide) (8). Challenge of neutrophils
with Hp(2-20) induced superoxide anion production (Fig.
3) with kinetics similar to that of an fMLF-induced response (Fig. 3, inset). The site of oxidant production is determined by the nature of the receptor engaged. This is
illustrated by the fact that activation through FPR promotes oxidase
assembly at the plasma membrane and rapid release of superoxide into
the extracellular milieu. In contrast, activation through surface receptors such as CR3 and CD66 promotes oxidase assembly on internal membranes (14, 24), generating ROS inside the phagocyte.
The neutrophil NADPH-oxidase activity induced by Hp(2-20) occurred exclusively at the plasma membrane (data not shown), and as a consequence, all the ROS produced was released extracellularly. The
superoxide anion production was completely abolished by the addition of
superoxide dismutase or by preincubation of the cells with the
NADPH-oxidase inhibitor diphenyleneiodonium (data not shown). Such a
release of ROS at sites of chronic inflammation not only may exert
their toxic effects on infecting microorganisms but also may inflict
damage on host cells and tissues (17), resulting in a
release of endogenous nutrients, promoting bacterial growth at the
inflammatory site (2).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Hp(2-20)-induced activation of the neutrophil
NADPH-oxidase. Hp(2-20) induces superoxide anion production with
kinetics resembling the kinetics of fMLF-induced superoxide anion
production. Pertussis toxin completely abolishes activation of the
neutrophil NADPH-oxidase, indicating that the activation is dependent
on signaling via a G-protein-coupled receptor. Neutrophils were
preincubated at 37°C for 60 min in the absence (solid line) or
presence (dotted line) of pertussis toxin (PT 500 ng/ml) and were then
stimulated with Hp(2-20) (100 µM) or fMLF (50 nM; inset). The
superoxide anion release was measured by isoluminol-enhanced
chemiluminescence (11). The arrows indicate the addition
of peptide.
|
|
Characterization of the receptor responsible for Hp(2-20)-induced
activation of Neutrophils.
The bactericidal activities of most
antibacterial proteins and peptides, including those belonging to the
cecropin family, are thought to be dependent on nonspecific
electrostatic interactions with bacterial membrane structures such as
phosphate residues of bacterial lipopolysaccharides (3,
12). In contrast, the cellular responses evoked in neutrophils
are usually dependent on the binding of an agonist to specific
receptors present in the plasma membrane of the cell (26).
As illustrated in Fig. 3, the oxidative response induced by Hp(2-20)
was abolished by preincubation of the cells with pertussis toxin, known
to specifically block the signaling induced by 7-transmembrane-spanning
receptors linked to Gi-type heterotrimeric G proteins
(27). This result indicates that Hp(2-20)-induced
activation is dependent on receptor binding.
A number of neutrophil chemoattractant receptors have been identified
and characterized (
28,
29), including FPR, the
LXA
4R/FPRL1,
the C5a receptor, the CXC chemokine
interleukin-8 receptor, the
receptor for platelet-activating factor,
and the leukotriene B
4 receptor. All these receptors have
been cloned by the use of exogenous
expression or homology
hybridization strategies, and all of them
belong to the
G-protein-linked 7-transmembrane family of receptors.
Some of these
receptors are highly specific with respect to the
activating
chemoattractant, whereas others are shared by many
different agonists.
The cellular responses induced by Hp(2-20)
are in many ways similar to
those induced by fMLF, suggesting
that the receptor engaged by Hp(2-20)
should possess similarities
with FPR. LXA
4R/FPRL1 was
originally isolated as an orphan receptor
by low-stringency
cross-hybridization with FPR cDNA and has 69%
sequence identity with
FPR (
21). The sequences of the two receptors
are
particularly similar in the transmembrane domains and the
intracellular
loops, suggesting that they transduce the same signals
downstream of
the receptor. The differences in the extracellular
domains imply that
the two receptors should bind to and be activated
by different ligands.
LXA
4R/FPRL1 is a promiscuous receptor that,
in addition to
the lipoxygenase-derived eicosanoid LXA
4 (
16),
also binds to at least five unrelated peptides and proteins (
10,
19,
25,
29), also making it an attractive receptor candidate
for
Hp(2-20).
Cells stably transfected with FPR or LXA
4R/FPRL1 were
investigated with respect to their ability to interact with Hp(2-20).
In a previous study, we had stably expressed either FPR or
LXA
4R/FPRL1
in HL-60 cells, a cell line of myeloid
origin that does not express
these receptors when the cells are
undifferentiated (
10). Addition
of the newly described
LXA
4R/FPRL1 agonist WKYMVm (
10) to
LXA
4R/FPRL1-expressing
cells induced a calcium
concentration rise that peaked at 450
nM (Fig.
4A, inset), and the application of
Hp(2-20) at a concentration
of 1 µM induced a calcium mobilization
with similar kinetics (Fig.
4A). In contrast, stimulation of
FPR-expressing cells with Hp(2-20)
of concentrations up to 10 µM did
not result in a calcium concentration
rise (Fig.
4B). The 50%
effective concentration of Hp(2-20)-induced
calcium mobilization in
LXA
4R/FPRL1-expressing cells was about
300 nM (Fig.
4C).
These results strongly suggest that Hp(2-20)
activates neutrophils
through LXA
4R/FPRL1 but not through FPR.
This was confirmed
by desensitization (
18) experiments with
neutrophils
performed with the agonist WKYMVm. Neutrophils first
activated with
WKYMVm were unable to generate a second burst of
superoxide when they
were challenged 10 min later with Hp(2-20)
(Fig.
5A). No such desensitization was obtained
with neutrophils
first challenged with fMLF at a concentration of 100 nM (Fig.
5B).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 4.
Hp(2-20)-induced calcium mobilization in transfected
HL-60 cells. Changes in cytosolic calcium in undifferentiated HL-60
cells stably transfected with either FPR or LXA4R/FPRL1
were measured by Fura-2 fluorescence. HL-60 cells transfected with
LXA4R/FPRL1 (A) and stimulated with Hp(2-20) (1 µM) or
WKYMVm (10 nM; inset) responded with a rise in the intracellular
calcium concentration. Cells transfected with FPR (B) showed an
increase in intracellular calcium concentration when they were
stimulated with a formylated peptide (fMLFK, 10 nM; inset) but not when
they were stimulated with Hp(2-20) (10 µM). The arrows indicate the
addition of agonists. (C) Relative increase in the cytosolic calcium
concentration induced by different concentrations of Hp(2-20) in
LXA4R/FPRL1-expressing cells. Peak values for the different
Hp(2-20) concentrations are given as a percentage of the maximal peak
value (obtained at 10 µM).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Desensitization of Hp(2-20)-induced NADPH-oxidase
activation. Binding of a chemoattractant to its G-protein-linked
7-transmembrane spanning receptor may induce NADPH-oxidase activation.
Phosphorylation and cytoskeletal coupling of the ligated receptor
terminate the response. This process is known as desensitization and
makes the cells unable to generate a second burst of superoxide if they
are challenged within 10 min with an activator that uses the same
receptor (18). Neutrophils were first activated with
WKYMVm (100 nM) (A) or fMLF (100 nM) (B), incubated for 10 min, and
then challenged with Hp(2-20) (50 µM). WKYMVm, but not fMLF, was able
to desensitize neutrophils against Hp(2-20) activation, implying that
Hp(2-20) activates neutrophils via LXA4R/FPRL1 but not FPR.
The superoxide anion release was measured by isoluminol-enhanced
chemiluminescence (11). The arrows indicate the time of
addition of agonists.
|
|
Concluding remarks.
Multiple microbial virulence factors have
been suggested to affect the inflammatory response during an H. pylori infection. The bacteria have developed a unique ability to
modulate neutrophil function, and earlier studies have identified a
150-kDa neutrophil-activating protein (Hp-NAP) as a key player in the
inflammatory response induced by H. pylori (1, 13,
23). We now introduce a new proinflammatory H. pylori
peptide that shares the basic functional characteristics of Hp-NAP;
both Hp(2-20) and Hp-NAP are neutrophil chemoattractants, they activate
the phagocyte NADPH-oxidase to produce and release ROS, and they are
potentially released from the bacteria after "altruistic"
lysis (1, 23).
Furthermore, we add Hp(2-20) to the array of agonists identified
by the neutrophil LXA
4R/FPRL1. LXA
4R/FPRL1 is
expressed by
a variety of cells of hematopoietic origin as well as in
hepatocytes
and epithelial cells (
28), suggesting that it
may play an important
role in both inflammatory and adaptive
immunological responses.
In addition to Hp(2-20),
LXA
4R/FPRL1 also recognizes WKYMVm, two
peptides derived
from human immunodeficiency virus type 1 (a leucine
zipper-like domain
of the human immunodeficiency virus type 1
envelope gp41 and a sequence
from the V4-C4 region of gp120, respectively)
(
19), a
necrotactic peptide derived from mitochondria (
6),
as well
as serum amyloid A, an acute-phase protein exhibiting
chemotactic
activity for both neutrophils and monocytes (
25).
The
Hp(2-20) peptide does not contain any reciprocal sequence
homologies to
any of the other agonists, a fact that is in agreement
with the
promiscuous feature of LXA
4R/FPRL1.
The presence of a cecropin-like sequence in the
H. pylori genome is consistent with the idea that cecropins have
their evolutionary
origin in a microbial parasite or symbiont
(
21a). Our data show
that the cecropin-like peptide
Hp(2-20) not only has a potent
antibacterial effect but also possesses
proinflammatory activity,
linking these two prominent features of
innate immunity. This
possibly implies that the inflammatory process
has evolved in
close connection with the more primitive defense
mechanism of
antibacterial peptides. The bactericidal as well as the
proinflammatory
activities of cecropin-like
H. pylori
peptides may be essential
for
H. pylori virulence, and it
will be intriguing to further
investigate whether both properties rely
on the same structural
features and whether the functional dualism
displayed by Hp(2-20)
is a general feature among cecropin-like
peptides.
 |
ACKNOWLEDGMENTS |
The work of the Swedish group of investigators was supported by
the Swedish Medical Research Council, the King Gustaf V 80-Year Foundation, the Fredrik and Ingrid Thuring Foundation, the Anna-Greta Crafoord Foundation for Rheumatological Research, the Vårdal
Foundation, The Swedish Society of Medicine, and the Swedish Foundation
for Strategic Research. The Work of the French group of investigators was supported by grants from the Commissariat à l'Energie
Atomique, the Centre National de la Recherche Scientifique (CNRS), and
the Université Joseph Fourier. Thierry Christophe is the
recipient of a fellowship from the Direction Général des
Armées.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: The Phagocyte
Research Laboratory, Department of Medical Microbiology and Immunology, University of Göteborg, Box 435, Göteborg, S-405 30 Sweden. Phone: 46-313424471. Fax: 46-31828898. E-mail:
Johan.Bylund{at}microbio.gu.se.
 |
REFERENCES |
| 1.
|
Allen, L. A.
2000.
Modulating phagocyte activation. The pros and cons of Helicobacter pylori virulence factors.
J. Exp. Med.
191:1451-1454[Free Full Text].
|
| 2.
|
Blaser, M. J.
1993.
Helicobacter pylori: microbiology of a `slow' bacterial infection.
Trends Microbiol.
1:255-260[CrossRef][Medline].
|
| 3.
|
Boman, H. G.
2000.
Innate immunity and the normal microflora.
Immunol. Rev.
173:5-16[CrossRef][Medline].
|
| 4.
|
Borregaard, N., and J. B. Cowland.
1997.
Granules of the human neutrophilic polymorphonuclear leukocyte.
Blood
89:3503-3521[Free Full Text].
|
| 5.
|
Boyum, A.,
D. Lovhaug,
L. Tresland, and E. M. Nordlie.
1991.
Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality.
Scand. J. Immunol.
34:697-712[CrossRef][Medline].
|
| 6.
|
Chiang, N.,
I. M. Fierro,
K. Gronert, and C. N. Serhan.
2000.
Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
J. Exp. Med.
191:1197-1208[Abstract/Free Full Text].
|
| 7.
|
Christophe, T.,
M. J. Rabiet,
M. Tardif,
M. D. Milcent, and F. Boulay.
2000.
Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
J. Biol. Chem.
275:1656-1664[Abstract/Free Full Text].
|
| 8.
|
Clark, R. A.
1999.
Activation of the neutrophil respiratory burst oxidase.
J. Infect. Dis.
179(Suppl. 2):S309-S317.
|
| 9.
|
Covacci, A.,
J. L. Telford,
G. Del Giudice,
J. Parsonnet, and R. Rappuoli.
1999.
Helicobacter pylori virulence and genetic geography.
Science
284:1328-1333[Abstract/Free Full Text].
|
| 10.
|
Dahlgren, C.,
T. Christophe,
F. Boulay,
P. N. Madianos,
M. J. Rabiet, and A. Karlsson.
2000.
The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Blood
95:1810-1818[Abstract/Free Full Text].
|
| 11.
|
Dahlgren, C., and A. Karlsson.
1999.
Respiratory burst in human neutrophils.
J. Immunol. Methods
232:3-14[CrossRef][Medline].
|
| 12.
|
Epand, R. M., and H. J. Vogel.
1999.
Diversity of antimicrobial peptides and their mechanisms of action.
Biochim. Biophys. Acta
1462:11-28[Medline].
|
| 13.
|
Evans, D. J., Jr.,
D. G. Evans,
T. Takemura,
H. Nakano,
H. C. Lampert,
D. Y. Graham,
D. N. Granger, and P. R. Kvietys.
1995.
Characterization of a Helicobacter pylori neutrophil-activating protein.
Infect. Immun.
63:2213-2220[Abstract].
|
| 14.
|
Feuk-Lagerstedt, E.,
E. T. Jordan,
H. Leffler,
C. Dahlgren, and A. Karlsson.
1999.
Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils.
J. Immunol.
163:5592-5598[Abstract/Free Full Text].
|
| 15.
|
Fiocca, R.,
O. Luinetti,
L. Villani,
A. M. Chiaravalli,
C. Capella, and E. Solcia.
1994.
Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis.
Scand. J. Gastroenterol. Suppl.
205:11-21.
|
| 16.
|
Fiore, S.,
J. F. Maddox,
H. D. Perez, and C. N. Serhan.
1994.
Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
J. Exp. Med.
180:253-260[Abstract/Free Full Text].
|
| 17.
|
Halliwell, B.
1994.
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Lancet
344:721-724[CrossRef][Medline].
|
| 18.
|
Klotz, K. N.,
K. L. Krotec,
J. Gripentrog, and A. J. Jesaitis.
1994.
Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils.
J. Immunol.
152:801-810[Abstract].
|
| 19.
|
Le, Y.,
W. Shen,
B. Li,
W. Gong,
N. M. Dunlop, and J. M. Wang.
1999.
A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
Forum (Genoa)
9:299-314.
|
| 20.
|
Mai, U. E.,
G. I. Perez-Perez,
J. B. Allen,
S. M. Wahl,
M. J. Blaser, and P. D. Smith.
1992.
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.
J. Exp. Med.
175:517-525[Abstract/Free Full Text].
|
| 21.
|
Murphy, P. M.,
T. Ozcelik,
R. T. Kenney,
H. L. Tiffany,
D. McDermott, and U. Francke.
1992.
A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family.
J. Biol. Chem.
267:7637-7643[Abstract/Free Full Text].
|
| 21a.
|
Putsep, K.,
C. I. Branden,
H. G. Boman, and S. Normark.
1999.
Antibacterial peptide from H. pylori.
Nature
398:671-672[CrossRef][Medline].
|
| 22.
|
Rautelin, H.,
B. Blomberg,
H. Fredlund,
G. Jarnerot, and D. Danielsson.
1993.
Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease.
Gut
34:599-603[Abstract/Free Full Text].
|
| 23.
|
Satin, B.,
G. Del Giudice,
V. Della Bianca,
S. Dusi,
C. Laudanna,
F. Tonello,
D. Kelleher,
R. Rappuoli,
C. Montecucco, and F. Rossi.
2000.
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.
J. Exp. Med.
191:1467-1476[Abstract/Free Full Text].
|
| 24.
|
Serrander, L.,
J. Larsson,
H. Lundqvist,
M. Lindmark,
M. Fallman,
C. Dahlgren, and O. Stendahl.
1999.
Particles binding beta(2)-integrins mediate intracellular production of oxidative metabolites in human neutrophils independently of phagocytosis.
Biochim. Biophys. Acta
1452:133-144[Medline].
|
| 25.
|
Su, S. B.,
W. Gong,
J. L. Gao,
W. Shen,
P. M. Murphy,
J. J. Oppenheim, and J. M. Wang.
1999.
A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells.
J. Exp. Med.
189:395-402[Abstract/Free Full Text].
|
| 26.
|
Uhing, R. J., and R. Snyderman.
1999.
Chemoattractant stimulus-response coupling, p. 607-626.
In
J. I. Gallin, and R. Snyderman (ed.), Inflammation: basic principles and clinical correlates, 3rd ed. Raven Press, New York, N.Y.
|
| 27.
|
West, R. E., Jr.,
J. Moss,
M. Vaughan,
T. Liu, and T. Y. Liu.
1985.
Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.
J. Biol. Chem.
260:14428-14430[Abstract/Free Full Text].
|
| 28.
|
Ye, R. D., and F. Boulay.
1997.
Structure and function of leukocyte chemoattractant receptors.
Adv. Pharmacol.
39:221-289.
|
| 29.
|
Yokomizo, T.,
T. Izumi,
K. Chang,
Y. Takuwa, and T. Shimizu.
1997.
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis.
Nature
387:620-624[CrossRef][Medline].
|
Antimicrobial Agents and Chemotherapy, June 2001, p. 1700-1704, Vol. 45, No. 6
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1700-1704.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
de Paulis, A., Prevete, N., Rossi, F. W., Rivellese, F., Salerno, F., Delfino, G., Liccardo, B., Avilla, E., Montuori, N., Mascolo, M., Staibano, S., Melillo, R. M., D'Argenio, G., Ricci, V., Romano, M., Marone, G.
(2009). Helicobacter pylori Hp(2-20) Promotes Migration and Proliferation of Gastric Epithelial Cells by Interacting with Formyl Peptide Receptors In Vitro and Accelerates Gastric Mucosal Healing In Vivo. J. Immunol.
183: 3761-3769
[Abstract]
[Full Text]
-
Bjorstad, A., Askarieh, G., Brown, K. L., Christenson, K., Forsman, H., Onnheim, K., Li, H.-N., Teneberg, S., Maier, O., Hoekstra, D., Dahlgren, C., Davidson, D. J., Bylund, J.
(2009). The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes. Antimicrob. Agents Chemother.
53: 1027-1038
[Abstract]
[Full Text]
-
Tran, A. X., Whittimore, J. D., Wyrick, P. B., McGrath, S. C., Cotter, R. J., Trent, M. S.
(2006). The Lipid A 1-Phosphatase of Helicobacter pylori Is Required for Resistance to the Antimicrobial Peptide Polymyxin.. J. Bacteriol.
188: 4531-4541
[Abstract]
[Full Text]
-
Fu, H., Karlsson, J., Bylund, J., Movitz, C., Karlsson, A., Dahlgren, C.
(2006). Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol.
79: 247-256
[Full Text]
-
Bjorstad, A., Fu, H., Karlsson, A., Dahlgren, C., Bylund, J.
(2005). Interleukin-8-Derived Peptide Has Antibacterial Activity. Antimicrob. Agents Chemother.
49: 3889-3895
[Abstract]
[Full Text]
-
Karlsson, J., Fu, H., Boulay, F., Dahlgren, C., Hellstrand, K., Movitz, C.
(2005). Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. J. Leukoc. Biol.
78: 762-771
[Abstract]
[Full Text]
-
Unemo, M., Aspholm-Hurtig, M., Ilver, D., Bergstrom, J., Boren, T., Danielsson, D., Teneberg, S.
(2005). The Sialic Acid Binding SabA Adhesin of Helicobacter pylori Is Essential for Nonopsonic Activation of Human Neutrophils. J. Biol. Chem.
280: 15390-15397
[Abstract]
[Full Text]
-
Allen, L.-A. H., Beecher, B. R., Lynch, J. T., Rohner, O. V., Wittine, L. M.
(2005). Helicobacter pylori Disrupts NADPH Oxidase Targeting in Human Neutrophils to Induce Extracellular Superoxide Release. J. Immunol.
174: 3658-3667
[Abstract]
[Full Text]
-
de Paulis, A., Prevete, N., Fiorentino, I., Walls, A. F., Curto, M., Petraroli, A., Castaldo, V., Ceppa, P., Fiocca, R., Marone, G.
(2004). Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2-20). J. Immunol.
172: 7734-7743
[Abstract]
[Full Text]
-
Bylund, J., Karlsson, A., Boulay, F., Dahlgren, C.
(2002). Lipopolysaccharide-Induced Granule Mobilization and Priming of the Neutrophil Response to Helicobacter pylori Peptide Hp(2-20), Which Activates Formyl Peptide Receptor-Like 1. Infect. Immun.
70: 2908-2914
[Abstract]
[Full Text]